Stock XLO XILIO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.18 USD -6.35% Intraday chart for Xilio Therapeutics, Inc. 0.00% +114.55%
Apr. 19 Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says MT
Apr. 01 Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
XILIO THERAPEUTICS, INC. Stock Xilio Therapeutics, Inc.
 43.55M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 44.96B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.65B
LONZA GROUP AG Stock Lonza Group AG
 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.08B
  1. Stock Market
  2. Equities
  3. XLO Stock
  4. Charts Xilio Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW